{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:47:55Z","timestamp":1790642875006,"version":"4.1.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.mehy.2004.03.036","type":"journal-article","created":{"date-parts":[[2004,6,2]],"date-time":"2004-06-02T20:58:06Z","timestamp":1086209886000},"page":"151-158","source":"Crossref","is-referenced-by-count":73,"title":["Nutraceutical resources for diabetes prevention \u2013 an update"],"prefix":"10.1016","volume":"64","author":[{"given":"Mark F.","family":"McCarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2004.03.036_BIB1","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1054\/mehy.1999.0952","article-title":"Toward practical prevention of type 2 diabetes","volume":"54","author":"McCarty","year":"2000","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mehy.2004.03.036_BIB2","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.03.036_BIB3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/00003495-200363100-00002","article-title":"Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?","volume":"63","author":"Scheen","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.mehy.2004.03.036_BIB4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.1997.03540300040031","article-title":"Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women","volume":"277","author":"Salmeron","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2004.03.036_BIB5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2337\/diacare.20.4.545","article-title":"Dietary fiber, glycemic load, and risk of NIDDM in men","volume":"20","author":"Salmeron","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2004.03.036_BIB6","doi-asserted-by":"crossref","first-page":"274S","DOI":"10.1093\/ajcn\/76.1.274S","article-title":"Glycemic index, glycemic load, and risk of type 2 diabetes","volume":"76","author":"Willett","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"issue":"Suppl 3","key":"10.1016\/j.mehy.2004.03.036_BIB7","first-page":"S190","article-title":"Effect of konjac fibre (glucomannan) on glucose and lipids","volume":"49","author":"Doi","year":"1995","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1054\/mehy.2001.1457","article-title":"Glucomannan minimizes the postprandial insulin surge: a potential adjuvant for hepatothermic therapy","volume":"58","author":"McCarty","year":"2002","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mehy.2004.03.036_BIB9","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/sj.ejcn.1601652","article-title":"Effects of a beverage containing an enzymatically induced-viscosity dietary fiber, with or without fructose, on the postprandial glycemic response to a high glycemic index food in humans","volume":"57","author":"Wolf","year":"2003","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.mehy.2004.03.036_BIB10","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0140-6736(02)11436-X","article-title":"Coffee consumption and risk of type 2 diabetes mellitus","volume":"360","author":"van Dam","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.03.036_BIB11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(03)12586-X","article-title":"Coffee consumption and risk of type 2 diabetes mellitus","volume":"361","author":"Isogawa","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2004.03.036_BIB12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2796.2003.01260.x","article-title":"Coffee and incidence of diabetes in Swedish women: a prospective 18-year follow-up study","volume":"255","author":"Rosengren","year":"2004","journal-title":"J. Int. Med."},{"key":"10.1016\/j.mehy.2004.03.036_BIB13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-140-1-200401060-00005","article-title":"Coffee consumption and risk for type diabetes mellitus","volume":"140","author":"Salazar-Martinez","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.mehy.2004.03.036_BIB14","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/jn\/119.11.1698","article-title":"Dietary phenolic compounds: inhibition of Na+-dependent d-glucose uptake in rat intestinal brush border membrane vesicles","volume":"119","author":"Welsch","year":"1989","journal-title":"J. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB15","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/ajcn\/78.4.728","article-title":"Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine","volume":"78","author":"Johnston","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/0026-0495(68)90158-3","article-title":"Effects of coffee ingestion on oral glucose tolerance curves in normal human subjects","volume":"17","author":"Feinberg","year":"1968","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2004.03.036_BIB17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1021\/jm9607360","article-title":"Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase","volume":"40","author":"Hemmerle","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB18","doi-asserted-by":"crossref","first-page":"11330","DOI":"10.1073\/pnas.211357698","article-title":"Normal kinetics of intestinal glucose absorption in the absence of GLUT2: evidence for a transport pathway requiring glucose phosphorylation and transfer into the endoplasmic reticulum","volume":"98","author":"Stumpel","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mehy.2004.03.036_BIB19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/gast.2003.50009","article-title":"Intestinal glucose transport: evidence for a membrane traffic-based pathway in humans","volume":"124","author":"Santer","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2004.03.036_BIB20","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.1016\/S0021-9258(19)40811-9","article-title":"Purification and properties of phaseolamin, an inhibitor of alpha-amylase, from the kidney bean, Phaseolus vulgaris","volume":"250","author":"Marshall","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1014122914134","article-title":"Primary structures of alpha- and beta-subunits of alpha-amylase inhibitors from seeds of three cultivars of Phaseolus beans","volume":"21","author":"Sawada","year":"2002","journal-title":"J. Protein Chem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB22","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1021\/jf020189t","article-title":"Protein structures of common bean (Phaseolus vulgaris) alpha-amylase inhibitors","volume":"50","author":"Lee","year":"2002","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB23","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM198212023072301","article-title":"Starch blockers \u2013 their effect on calorie absorption from a high-starch meal","volume":"307","author":"Bo-Linn","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mehy.2004.03.036_BIB24","first-page":"301","article-title":"A study of `starch blockers' in man using 13C-enriched starch as a tracer","volume":"37","author":"Garrow","year":"1983","journal-title":"Hum. Nutr. Clin. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB25","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/ajcn\/38.4.498","article-title":"Effects of a commercial starch blocker preparation on carbohydrate digestion and absorption: in vivo and in vitro studies","volume":"38","author":"Hollenbeck","year":"1983","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB26","unstructured":"Anon. Starch blockers do not block starch digestion. Nutr Rev 1985;43:46\u20138"},{"key":"10.1016\/j.mehy.2004.03.036_BIB27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/0148607197021005290","article-title":"In vitro fermentation of high-amylose cornstarch by a mixed population of colonic bacteria","volume":"21","author":"Christl","year":"1997","journal-title":"J. Parenter. Enteral Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ajcn\/67.1.136","article-title":"Effects of resistant starch on the colon in healthy volunteers: possible implications for cancer prevention","volume":"67","author":"Hylla","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2004.03.036_BIB30","first-page":"1","article-title":"Cholesterol-lowering properties and safety of chitosan","volume":"52","author":"Ylitalo","year":"2002","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.mehy.2004.03.036_BIB31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.ejcn.1601603","article-title":"Chitosan decreases total cholesterol in women: a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Bokura","year":"2003","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB32","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mehy.2004.03.036_BIB33","doi-asserted-by":"crossref","first-page":"25226","DOI":"10.1074\/jbc.M202489200","article-title":"The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways","volume":"277","author":"Fryer","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB34","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2337\/diabetes.51.7.2074","article-title":"Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes","volume":"51","author":"Musi","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2004.03.036_BIB35","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.2337\/diabetes.51.8.2420","article-title":"The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism","volume":"51","author":"Hawley","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2004.03.036_BIB36","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854\u201365","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"10.1016\/j.mehy.2004.03.036_BIB37","doi-asserted-by":"crossref","first-page":"6S36, 6S43","DOI":"10.1016\/S1262-3636(03)72786-4","article-title":"Improving survival with metformin: the evidence base today","volume":"29","author":"Scarpello","year":"2003","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.mehy.2004.03.036_BIB38","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1126\/science.6123152","article-title":"Biotin enhances guanylate cyclase activity","volume":"216","author":"Vesely","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.mehy.2004.03.036_BIB39","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1016\/S0021-9258(20)82154-1","article-title":"Effects of biotin upon the intracellular level of cGMP and the activity of glucokinase in cultured rat hepatocytes","volume":"259","author":"Spence","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB40","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0024-3205(99)00392-6","article-title":"Nitric oxide-cyclic GMP system potentiates glucose-induced rise in cytosolic Ca2+ concentration in rat pancreatic beta-cells","volume":"65","author":"Matsuura","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.mehy.2004.03.036_BIB41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1254\/jphs.91.41","article-title":"Two distinct effects of cGMP on cytosolic Ca2+ concentration of rat pancreatic beta-cells","volume":"91","author":"Ishikawa","year":"2003","journal-title":"J. Pharmacol Sci."},{"key":"10.1016\/j.mehy.2004.03.036_BIB42","doi-asserted-by":"crossref","first-page":"C1215","DOI":"10.1152\/ajpcell.00223.2002","article-title":"Dual effect of nitric oxide on cytosolic Ca2+ concentration and insulin secretion in rat pancreatic beta-cells","volume":"284","author":"Kaneko","year":"2003","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.mehy.2004.03.036_BIB43","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/diabetes.51.4.994","article-title":"Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function\/survival after transplantation","volume":"51","author":"Gunther","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2004.03.036_BIB44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/meta.2002.29979","article-title":"Effects of biotin on glucotoxicity or lipotoxicity in rat pancreatic islets","volume":"51","author":"Yoshikawa","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2004.03.036_BIB45","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.2337\/diabetes.49.12.1978","article-title":"Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase","volume":"49","author":"Fryer","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2004.03.036_BIB46","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1126\/science.1079368","article-title":"Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide","volume":"299","author":"Nisoli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.mehy.2004.03.036_BIB47","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1073\/pnas.061035098","article-title":"Restoration of insulin-sensitive glucose transporter (GLUT4) gene expression in muscle cells by the transcriptional coactivator PGC-1","volume":"98","author":"Michael","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.mehy.2004.03.036_BIB48","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S0021-9258(19)69847-9","article-title":"Role of insulin, glucose, and cyclic GMP in the regulation of glucokinase in cultured hepatocytes","volume":"256","author":"Spence","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/BF00926921","article-title":"Transcriptional regulation of liver phosphoenolpyruvate carboxykinase by biotin in diabetic rats","volume":"132","author":"Dakshinamurti","year":"1994","journal-title":"Mol. Cell Biochem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1749-6632.1985.tb18454.x","article-title":"Biotin status and plasma glucose in diabetics","volume":"447","author":"Coggeshall","year":"1985","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.mehy.2004.03.036_BIB51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3164\/jcbn.14.211","article-title":"Therapeutic evaluation of the effect of biotin on hyperglycemia in patients with non-insulin-dependent diabetes mellitus","volume":"14","author":"Maebashi","year":"1993","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB52","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0024-3205(88)90226-3","article-title":"Biotin supplementation improves glucose and insulin tolerances in genetically diabetic KK mice","volume":"42","author":"Reddi","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.mehy.2004.03.036_BIB53","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3177\/jnsv.42.517","article-title":"A high biotin diet improves the impaired glucose tolerance of long-term spontaneously hyperglycemic rats with non-insulin-dependent diabetes mellitus","volume":"42","author":"Zhang","year":"1996","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.mehy.2004.03.036_BIB54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3177\/jnsv.43.271","article-title":"Biotin administration improves the impaired glucose tolerance of streptozotocin-induced diabetic Wistar rats","volume":"43","author":"Zhang","year":"1997","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.mehy.2004.03.036_BIB55","series-title":"Present knowledge in nutrition","first-page":"220","author":"Mock","year":"1996"},{"key":"10.1016\/j.mehy.2004.03.036_BIB56","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0008-6363(02)00327-9","article-title":"Vasoprotection by nitric oxide: mechanisms and therapeutic potential","volume":"55","author":"Gewaltig","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.mehy.2004.03.036_BIB57","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/diabetes.46.11.1786","article-title":"Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes","volume":"46","author":"Anderson","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2004.03.036_BIB58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/(SICI)1520-670X(1999)12:2<55::AID-JTRA2>3.0.CO;2-G","article-title":"Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium","volume":"12","author":"Cheng","year":"1999","journal-title":"J. Trace Elem. Exp. Med."},{"key":"10.1016\/j.mehy.2004.03.036_BIB59","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/ajcn\/78.1.191","article-title":"Chromium meta-analysis","volume":"78","author":"McCarty","year":"2003","journal-title":"Am. J. Clin Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB60","first-page":"A349","article-title":"Effect of chromium picolinate on insulin levels and glucose control in obese patients with type-II diabetes mellitus","volume":"48","author":"Bahadori","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2004.03.036_BIB61","first-page":"19","article-title":"Life span is increased in rats supplemented with a chromium-pyridine-2-carboxylate complex","volume":"1","author":"Evans","year":"1994","journal-title":"Adv. Sci. Res."},{"key":"10.1016\/j.mehy.2004.03.036_BIB62","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/ajcn\/55.5.1018","article-title":"Diet and risk of clinical diabetes in women","volume":"55","author":"Colditz","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB63","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/jama.1997.03540460027023","article-title":"Fiber intake and risk of developing non-insulin-dependent diabetes mellitus","volume":"277","author":"Nadler","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.mehy.2004.03.036_BIB64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2337\/diacare.27.1.59","article-title":"Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women","volume":"27","author":"Song","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2004.03.036_BIB65","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2337\/diacare.27.1.134","article-title":"Magnesium intake and risk of type 2 diabetes in men and women","volume":"27","author":"Lopez-Ridaura","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2004.03.036_BIB66","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1080\/07315724.2003.10719332","article-title":"The association between magnesium intake and fasting insulin concentration in healthy middle-aged women","volume":"22","author":"Fung","year":"2003","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB67","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/ajcn\/78.5.965","article-title":"Whole-grain intake and insulin sensitivity: the Insulin Resistance Atherosclerosis Study","volume":"78","author":"Liese","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB68","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF00404136","article-title":"Magnesium and glucose homeostasis","volume":"33","author":"Paolisso","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.mehy.2004.03.036_BIB69","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0895-7061(96)00342-1","article-title":"Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium","volume":"10","author":"Paolisso","year":"1997","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.mehy.2004.03.036_BIB70","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1161\/01.HYP.23.6.1036","article-title":"Dietary magnesium prevents fructose-induced insulin insensitivity in rats","volume":"23","author":"Balon","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.mehy.2004.03.036_BIB71","first-page":"E745","article-title":"Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM","volume":"269","author":"Balon","year":"1995","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.mehy.2004.03.036_BIB72","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0026-0495(96)90156-0","article-title":"Magnesium deficiency and glucose metabolism in rat adipocytes","volume":"45","author":"Kandeel","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2004.03.036_BIB73","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2337\/diacare.21.5.682","article-title":"The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes","volume":"21","author":"Lima","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2004.03.036_BIB74","doi-asserted-by":"crossref","unstructured":"McCarty MF. Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist. Med Hypotheses 2004;in press","DOI":"10.1016\/j.mehy.2003.10.034"},{"key":"10.1016\/j.mehy.2004.03.036_BIB75","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1210\/en.135.5.1837","article-title":"Effects of parathyroid hormone on cytosolic calcium of rat adipocytes","volume":"135","author":"Ni","year":"1994","journal-title":"Endocrinology"},{"key":"10.1016\/j.mehy.2004.03.036_BIB76","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.1016\/S0021-9258(18)42648-8","article-title":"Calcium-induced inhibition of phosphoserine phosphatase in insulin target cells is mediated by the phosphorylation and activation of inhibitor 1","volume":"267","author":"Begum","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB77","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1016\/S0021-9258(18)53700-5","article-title":"Inverse relationship between GLUT-4 phosphorylation and its intrinsic activity","volume":"268","author":"Reusch","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB78","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI111765","article-title":"Role of parathyroid hormone in the glucose intolerance of chronic renal failure","volume":"75","author":"Akmal","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mehy.2004.03.036_BIB79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02555816","article-title":"Evaluation of glucose tolerance, insulin secretion, and insulin action in patients with primary hyperparathyroidism before and after surgery","volume":"46","author":"Prager","year":"1990","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.mehy.2004.03.036_BIB80","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2265.1992.tb02299.x","article-title":"Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery","volume":"37","author":"Kautzky-Willer","year":"1992","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.mehy.2004.03.036_BIB81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2265.1994.tb02442.x","article-title":"Impaired glucose tolerance and insulin insensitivity in primary hyperparathyroidism","volume":"40","author":"Kumar","year":"1994","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"10.1016\/j.mehy.2004.03.036_BIB82","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.1995.24","article-title":"Intravenous calcitriol normalizes insulin sensitivity in uremic patients","volume":"47","author":"Kautzky-Willer","year":"1995","journal-title":"Kidney Int."},{"key":"10.1016\/j.mehy.2004.03.036_BIB83","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1046\/j.1464-5491.2002.00809.x","article-title":"The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed type 2 diabetes mellitus in primary hyperparathyroidism","volume":"19","author":"Procopio","year":"2002","journal-title":"Diabet. Med."},{"key":"10.1016\/j.mehy.2004.03.036_BIB84","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1053\/meta.2000.17708","article-title":"Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level","volume":"49","author":"Chiu","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.mehy.2004.03.036_BIB85","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s001250050685","article-title":"Vitamin D, glucose tolerance and insulinaemia in elderly men","volume":"40","author":"Baynes","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.mehy.2004.03.036_BIB86","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/BF00422375","article-title":"Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians","volume":"38","author":"Boucher","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/j.mehy.2004.03.036_BIB87","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1517\/13543784.12.7.1179","article-title":"Thiazolidinediones \u2013 some recent developments","volume":"12","author":"Stumvoll","year":"2003","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.mehy.2004.03.036_BIB88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1388-1981(02)00126-9","article-title":"Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism","volume":"1581","author":"Yu","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mehy.2004.03.036_BIB89","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1042\/bst0311075","article-title":"Regression of pre-established atherosclerosis in the apoE-\/- mouse by conjugated linoleic acid","volume":"31","author":"Toomey","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.mehy.2004.03.036_BIB90","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1006\/bbrc.1998.8303","article-title":"Dietary conjugated linoleic acid normalizes impaired glucose tolerance in the Zucker diabetic fatty (fa\/fa) rat","volume":"244","author":"Houseknecht","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mehy.2004.03.036_BIB91","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2337\/diabetes.50.5.1149","article-title":"Isomer-specific antidiabetic properties of conjugated linoleic acid. Improved glucose tolerance, skeletal muscle insulin action, and UCP-2 gene expression","volume":"50","author":"Ryder","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.mehy.2004.03.036_BIB92","doi-asserted-by":"crossref","first-page":"E98","DOI":"10.1152\/ajpendo.00013.2003","article-title":"Isomer-specific actions of conjugated linoleic acid on muscle glucose transport in the obese Zucker rat","volume":"285","author":"Henriksen","year":"2003","journal-title":"Am. J. Physiol. Endocrinol Metab."},{"key":"10.1016\/j.mehy.2004.03.036_BIB93","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2003.09.044","article-title":"Conjugated linoleic acid enhances plasma adiponectin level and alleviates hyperinsulinemia and hypertension in Zucker diabetic fatty (fa\/fa) rats","volume":"310","author":"Nagao","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mehy.2004.03.036_BIB94","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/diacare.25.9.1516","article-title":"Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome","volume":"25","author":"Riserus","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2004.03.036_BIB95","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1161\/01.CIR.0000033589.15413.48","article-title":"Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance","volume":"106","author":"Riserus","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2004.03.036_BIB96","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.ijo.0802068","article-title":"The chlorophyll-derived metabolite phytanic acid induces white adipocyte differentiation","volume":"26","author":"Schluter","year":"2002","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.mehy.2004.03.036_BIB97","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1432-1033.1996.00328.x","article-title":"Phytanic acid is a retinoid X receptor ligand","volume":"236","author":"Lemotte","year":"1996","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.mehy.2004.03.036_BIB98","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/386407a0","article-title":"Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists","volume":"386","author":"Mukherjee","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2004.03.036_BIB99","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/sj.ijo.0801351","article-title":"Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa\/fa rats","volume":"24","author":"Liu","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.mehy.2004.03.036_BIB100","first-page":"249","article-title":"PPAR gamma\/RXR as a molecular target for diabetes","volume":"7","author":"Lenhard","year":"2001","journal-title":"Receptors Channels"},{"key":"10.1016\/j.mehy.2004.03.036_BIB101","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1124\/mol.59.4.765","article-title":"Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents","volume":"59","author":"Singh","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.mehy.2004.03.036_BIB102","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1054\/mehy.2000.1153","article-title":"The chlorophyll metabolite phytanic acid is a natural rexinoid \u2013 potential for treatment and prevention of diabetes","volume":"56","author":"McCarty","year":"2001","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mehy.2004.03.036_BIB103","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1096\/fj.01-0816fje","article-title":"Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes","volume":"16","author":"Heim","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.mehy.2004.03.036_BIB104","first-page":"1327","article-title":"Herbal medicine in the treatment of diabetes mellitus","volume":"23","author":"Al Rowais","year":"2002","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.mehy.2004.03.036_BIB105","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2337\/diacare.26.4.1277","article-title":"Systematic review of herbs and dietary supplements for glycemic control in diabetes","volume":"26","author":"Yeh","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2004.03.036_BIB106","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ptr.1398","article-title":"Antidiabetic herbal drugs officially approved in China","volume":"17","author":"Jia","year":"2003","journal-title":"Phytother. Res."},{"key":"10.1016\/j.mehy.2004.03.036_BIB107","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/bmj.282.6279.1823","article-title":"Improvement in glucose tolerance due to Momordica charantia (karela)","volume":"282","author":"Leatherdale","year":"1981","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"10.1016\/j.mehy.2004.03.036_BIB108","first-page":"106","article-title":"Trial of Momordica charantia Linn (Karela) powder in patients with maturity-onset diabetes","volume":"32","author":"Akhtar","year":"1982","journal-title":"J. Pak. Med. Assoc."},{"key":"10.1016\/j.mehy.2004.03.036_BIB109","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0378-8741(86)90116-9","article-title":"Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes","volume":"17","author":"Welihinda","year":"1986","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mehy.2004.03.036_BIB110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-2006-961003","article-title":"Hypoglycaemic effect of Momordica charantia extracts","volume":"56","author":"Day","year":"1990","journal-title":"Planta Med."},{"key":"10.1016\/j.mehy.2004.03.036_BIB111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/phrs.1996.0001","article-title":"Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes","volume":"33","author":"Sarkar","year":"1996","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mehy.2004.03.036_BIB112","first-page":"11","article-title":"Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients","volume":"25","author":"Ahmad","year":"1999","journal-title":"Bangladesh Med. Res. Counc. Bull."},{"key":"10.1016\/j.mehy.2004.03.036_BIB113","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0378-8741(01)00324-5","article-title":"Antihyperglycemic activity of Momordica cymbalaria in alloxan diabetic rats","volume":"78","author":"Rao","year":"2001","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mehy.2004.03.036_BIB114","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3177\/jnsv.47.340","article-title":"Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice","volume":"47","author":"Miura","year":"2001","journal-title":"J. Nutr. Sci. Vitaminol. (Tokyo)"},{"key":"10.1016\/j.mehy.2004.03.036_BIB115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ptr.842","article-title":"The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism","volume":"16","author":"Rathi","year":"2002","journal-title":"Phytother. Res."},{"key":"10.1016\/j.mehy.2004.03.036_BIB116","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ajhp\/60.4.356","article-title":"Bitter melon (Momordica charantia): a review of efficacy and safety","volume":"60","author":"Basch","year":"2003","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.mehy.2004.03.036_BIB117","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0378-8741(03)00184-3","article-title":"Antihyperglycemic effects of three extracts from Momordica charantia","volume":"88","author":"Virdi","year":"2003","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mehy.2004.03.036_BIB118","doi-asserted-by":"crossref","unstructured":"McCarty MF. Does bitter melon contain an activator of AMP-activated kinase? Med Hypotheses 2004;in press","DOI":"10.1016\/j.mehy.2004.01.041"},{"key":"10.1016\/j.mehy.2004.03.036_BIB119","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000023270","article-title":"Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling","volume":"50","author":"Imparl-Radosevich","year":"1998","journal-title":"Horm. Res."},{"key":"10.1016\/j.mehy.2004.03.036_BIB120","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.2337\/diacare.26.12.3215","article-title":"Cinnamon improves glucose and lipids of people with type 2 diabetes","volume":"26","author":"Khan","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mehy.2004.03.036_BIB121","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF00052777","article-title":"Insulin and colon cancer","volume":"6","author":"Giovannucci","year":"1995","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.mehy.2004.03.036_BIB122","doi-asserted-by":"crossref","first-page":"3109S","DOI":"10.1093\/jn\/131.11.3109S","article-title":"Insulin, insulin-like growth factors and colon cancer: a review of the evidence","volume":"131","author":"Giovannucci","year":"2001","journal-title":"J. Nutr."},{"key":"10.1016\/j.mehy.2004.03.036_BIB123","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1055\/s-2004-814147","article-title":"Nutrition, insulin, insulin-like growth factors and cancer","volume":"35","author":"Giovannucci","year":"2003","journal-title":"Horm. Metab. Res."}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704002750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704002750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T20:30:37Z","timestamp":1624393837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987704002750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0306987704002750"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2004.03.036","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}